Chronic Kidney Disease
3 competing products in clinical development for Chronic Kidney Disease.
Pipeline by Phase
Pre-clinical1
Phase 21
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Empagliflozin + Matching placebo | Eli Lilly | Phase 3 | Completed | 77 |
| LY2623091 + Eplerenone | Eli Lilly | Phase 2 | Completed | 52 |
| SGLT2 inhibitor | Eli Lilly | Pre-clinical | Active | 23 |